$CABA
Cabaletta Bio, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Philadelphia, PA
CABA chart
What traders are saying about $CABA
Latest postsCabaletta Bio, Inc. news
- Citigroup maintains Cabaletta Bio at Buy, lowers price target to $8 from $10
TradingView ·
- Cabaletta Bio, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Cabaletta Bio Reports Durable Phase 1/2 Rese-cel Results
TipRanks ·
- Cabaletta Bio (CABA) Presents Promising Phase 1/2 Data on Rese-cel Therapy at ACR Convergence 2026
GuruFocus ·
- Cabaletta Bio reports year-long rese‑cel responses in six myositis patients
Mugglehead Investment Magazine ·
- Cabaletta Bio reports phase 1/2 data for autoimmune therapy By Investing.com
Investing.com Nigeria ·
- Cabaletta Bio Presents New Rese-cel Phase 1/2 Clinical Data at ACR...
Quantisnow ·
- Cabaletta Bio Presents New Rese-cel Phase 1/2 Clinical Data at ACR Convergence 2026 Featuring Immunomodulator-Free Durability and Favorable Benefit-Risk Profile Across Autoimmune Diseases
Yahoo Finance ·
- T. Rowe Price updates its Cabaletta Bio (CABA) stake disclosure, with its small-cap value fund at 7.1%.
Stock Titan ·
- T. Rowe Price amends its reported ownership in Cabaletta Bio (CABA).
Stock Titan ·
- Cabaletta Bio (NasdaqGS:CABA) Stock Forecast & Analyst Predictions
Simply Wall St ·
- Cabaletta Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
www.marketscreener.com ·
Cabaletta Bio, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$167.9M | -$115.9M | -$67.7M | -$53.0M |
| Diluted EPS | $-2.10 | $-2.34 | $-1.65 | $-1.81 |
| Total assets (year end) | $165.1M | $185.0M | $253.7M | $117.0M |
| Cash and equivalents (year end) | $83.0M | $164.0M | $193.2M | $81.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Cabaletta Bio, Inc.
- Ticker
- CABA (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Philadelphia, PA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1759138
Frequently asked questions
What exchange is Cabaletta Bio, Inc. listed on?
Cabaletta Bio, Inc. trades on the Nasdaq under the ticker symbol CABA.
What industry is Cabaletta Bio, Inc. in?
Cabaletta Bio, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Cabaletta Bio, Inc. headquartered?
Cabaletta Bio, Inc.'s business address on file with the SEC is in Philadelphia, PA.
When does Cabaletta Bio, Inc.'s fiscal year end?
Cabaletta Bio, Inc.'s fiscal year ends on December 31.